SUPPLEMENTARY NOTES
It has been recently observed that eosinophilia and abnormal production of eosinophil products occur in many patients with advanced HIV infection (4,5). May and colleagues reported two cases of a predominantly cutaneous hypereosinophilic syndrome in HIVinfected patients with advanced disease (6) . We present an additional case of this entity in whom IL-5, a cytokine which regulates eosinophil production, was found to be elevated during the eruption but was not in prior or subsequent samplings. Aliquots of sera samples held at -70 degrees C obtained before, during and after the patient's eruption were tested with controls using specific immunoenzymatic assays in duplicate for IL-5 and IL-4 as previously described (7, 8) .
The limits for detectability in the assays are 25 pg/mcl for IL-4 and 10 pg/mcl for IL-5. The specificity of these assays and their performance characteristics have been described previously (9, 10) . Results in are presented in Table 1 . In summary, we have presented the case of a young man with AIDS who developed an intensely pruritic, erythematous skin eruption associated with hypereosinophilia which responded to corticosteroids and PUVA therapy. This syndrome was associated with a measurably elevated serum IL-5, a cytokine which regulates eosinophil production, although a cause and effect relationship between IL-5 and this entity will require further investigation.
